OCIAD1-AS1: OCIAD1-AS1 is an immune-related long non-coding RNA (lncRNA) that has been identified in several studies as a potential prognostic marker for bladder cancer (BLCA) [PMC9881817] [PMC9827344] [PMC8828980] [PMC8413054] [PMC9794272] [PMC9393225] [PMC8635160]. It is one of the lncRNAs included in prognostic signatures for BLCA patients, along with other lncRNAs such as USP30-AS1, LINC02321, PSMB8-AS1, KRT7-AS, and LINC01767 [PMC9827344]. The expression of OCIAD1-AS1 has been found to be significantly lower in BLCA cell lines [PMC8828980]. Additionally, OCIAD1-AS1 has been associated with the regulation of GPM6B/AKAP11 and the interaction with miR-141-3p and miR-200a-3p in bladder cancer mechanisms [PMC9393225]. It has also been included in a predictive model for bladder cancer patients along with other pyroptosis-related lncRNAs such as SNHG18, SLC25A25-AS1, MAFG-DT, TRIM31-AS1, and PSMB8-AS1 [PMC9393225]. Furthermore, OCIAD1-AS1 has been identified as a protective factor for bladder cancer patients with HR < 1 and high expression levels of OCIAD1-AS1 have shown better overall survival rates compared to low expression levels [PMC9393225].